These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 23506956)
21. Development of a gastroretentive pulsatile drug delivery platform. Thitinan S; McConville JT J Pharm Pharmacol; 2012 Apr; 64(4):505-16. PubMed ID: 22420657 [TBL] [Abstract][Full Text] [Related]
22. Stability of aqueous polymeric controlled release film coatings. Siepmann J; Siepmann F Int J Pharm; 2013 Dec; 457(2):437-45. PubMed ID: 24126037 [TBL] [Abstract][Full Text] [Related]
23. Site specific chronotherapeutic drug delivery systems: a patent review. Saigal N; Baboota S; Ahuja A; Ali J Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):64-70. PubMed ID: 19149730 [TBL] [Abstract][Full Text] [Related]
24. Distinctive features of "chronotherapeutic" and "pulsatile" drug delivery systems negating the practice of their interchangeable terminology. Ali J; Baboota S; Ahuja A; Saigal N J Drug Target; 2010 Jul; 18(6):413-9. PubMed ID: 20132094 [TBL] [Abstract][Full Text] [Related]
25. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475 [TBL] [Abstract][Full Text] [Related]
26. Chronopharmaceutics: as a clinically relevant drug delivery system. Gandhi BR; Mundada AS; Gandhi PP Drug Deliv; 2011 Jan; 18(1):1-18. PubMed ID: 21138394 [TBL] [Abstract][Full Text] [Related]
27. Tailoring controlled-release oral dosage forms by combining inkjet and flexographic printing techniques. Genina N; Fors D; Vakili H; Ihalainen P; Pohjala L; Ehlers H; Kassamakov I; Haeggström E; Vuorela P; Peltonen J; Sandler N Eur J Pharm Sci; 2012 Oct; 47(3):615-23. PubMed ID: 22902482 [TBL] [Abstract][Full Text] [Related]
28. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs. Efentakis M; Naseef H; Vlachou M Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641 [TBL] [Abstract][Full Text] [Related]
29. Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma. Kadam VD; Gattani SG Drug Deliv; 2010 Jul; 17(5):343-51. PubMed ID: 20429842 [TBL] [Abstract][Full Text] [Related]
30. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. Roy P; Shahiwala A J Control Release; 2009 Mar; 134(2):74-80. PubMed ID: 19105973 [TBL] [Abstract][Full Text] [Related]
31. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma. Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847 [TBL] [Abstract][Full Text] [Related]
32. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers. Kadam VD; Gattani SG Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544 [TBL] [Abstract][Full Text] [Related]
33. Injection Molding and its application to drug delivery. Zema L; Loreti G; Melocchi A; Maroni A; Gazzaniga A J Control Release; 2012 May; 159(3):324-31. PubMed ID: 22245483 [TBL] [Abstract][Full Text] [Related]
34. Extrudable core system: development of a single-layer osmotic controlled-release tablet. Waterman KC; MacDonald BC; Roy MC J Control Release; 2009 Mar; 134(3):201-6. PubMed ID: 19100796 [TBL] [Abstract][Full Text] [Related]
35. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract. Liu F; Moreno P; Basit AW Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177 [TBL] [Abstract][Full Text] [Related]
36. Pharmaceutically used polymers: principles, structures, and applications of pharmaceutical delivery systems. Khandare J; Haag R Handb Exp Pharmacol; 2010; (197):221-50. PubMed ID: 20217532 [TBL] [Abstract][Full Text] [Related]
37. Polymer blends used for the aqueous coating of solid dosage forms: importance of the type of plasticizer. Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R J Control Release; 2004 Sep; 99(1):1-13. PubMed ID: 15342176 [TBL] [Abstract][Full Text] [Related]
38. Recent Advancement and Technological Aspects of Pulsatile Drug Delivery System - A Laconic Review. Pandit V; Kumar A; Ashawat MS; Verma CP; Kumar P Curr Drug Targets; 2017; 18(10):1191-1203. PubMed ID: 26853323 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of powder-layering vs. spray-coating techniques in the manufacturing of a swellable/erodible pulsatile delivery system. Foppoli A; Cerea M; Palugan L; Zema L; Melocchi A; Maroni A; Gazzaniga A Drug Dev Ind Pharm; 2020 Aug; 46(8):1230-1237. PubMed ID: 32597251 [TBL] [Abstract][Full Text] [Related]
40. Use of scoring to induce reproducible drug delivery from osmotic pulsatile tablets. Rahemba TR; Bell S; Connolly EK; Waterman KC Pharm Dev Technol; 2009; 14(5):548-55. PubMed ID: 19552560 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]